Skip to main content
About the Institute
  • English
  • Français
  • Español
  • Russian
  • Portuguese

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Severity-specific signature of gut microbiota in chronic kidney disease
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Gastroenterology
  3. Severity-specific signature of gut microbiota in chronic kidney disease
Gastroenterology

Severity-specific signature of gut microbiota in chronic kidney disease

Nephro condition
Nephrology Gastroenterology

Intestinal bacteria and blood metabolites signal the progression of chronic kidney disease. In addition to the discovery of potential new biomarkers, investigation in this area is also revealing etiological leads.

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographic
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • Mail

About this article

Created 11 September 2020
Updated 31 March 2022

Chronic kidney disease (CKD) is associated with specific changes in the gut microbiota and circulating metabolites. However, the functions of the microbiota and its complex relationship with the host’s metabolism during the progression of CKD are still only loosely understood. Hence this study involving 72 patients with CKD at different severity stages (26 mild, 26 moderate and 20 advanced cases) and 20 control subjects with normal renal function. Fecal samples were subjected to (sidenote:  Shotgun sequencing method is more accurate than 16S rARN. ) , while blood metabolite profiling was performed, targeting bile acids (BA), short- and medium-chain fatty acids and uremic toxins.

A bacterial and metabolic signature

13 bacterial species and 6 circulating metabolites experienced significant changes (increases or decreases) from early to advanced stages of CKD, or at a specific stage or stages only. For example, Bacteroides eggerthii distinguished control subjects from patients in the early stages of CKD, while Prevotella sp. 885 correlated with urea excretion and reflected progression of the disease. Some gut bacteria can therefore act as useful biomarkers for the early diagnosis and monitoring of CKD. As regards metabolites, propionic acid decreased significantly in late stages of CKD, with its absence strongly signaling advanced patients.

Etiological leads

Bacterial genes associated with the biosynthesis of secondary BA were found to be more prevalent in the early stage of CKD, indicating that the conversion of primary BA into secondary BA by intestinal bacteria occurs at the onset of kidney function decline. The advanced stages of the disease were correlated with enrichment of pathways linked:

– on the one hand, to the metabolism of (sidenote: Steroids, ether lipids, polyunsaturated fatty acids )  (probably involved in metabolic syndrome, which is often associated with dyslipidemia, known to be an etiological factor in CKD)

– and, on the other hand, to the biosynthesis of lipopolysaccharides (LPS, inflammatory endotoxins) Therefore, changes in the metabolism of the microbiota and inflammation in the host are thought to influence renal health.

Bacteria-metabolite links

The team identified gut bacteria linked to changes in circulating metabolites, suggesting the potential involvement of the intestinal microbiota in the development of CKD. For example, the notable decrease in B. eggerthii in CKD patients was correlated with the synthesis of secondary BA at an early stage of the disease. Similarly, the increased synthesis of LPS in late stages was partly attributed to an increase in Escherichia coli and other Enterobacteriaceae. These bacteria-metabolite links may indicate either that the bacterial species produces this metabolite or that the metabolite enhances/inhibits the growth of the bacterial species. In sum, this clearer understanding of the relationship between intestinal bacteria species and host metabolism at different stages of CKD provides potential etiological and diagnostic leads for the disease.

1 A high throughput DNA sequencing technique, known as “random sequencing”, which allows large quantities of DNA to be sequenced in very short periods. This method can be used to sequence entire genomes, for example.

Sources

Wu IW, Gao SS, Chou HC et al. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Theranostics. 2020 Apr 6;10(12):5398-5411.

Tags
Kidney Dysbiosis Biomarker Bile acids Urea

en_view en_sources

    Created 11 September 2020
    Updated 31 March 2022

    About this article

    To know more about this topic.

    Main topic

    Nephro condition

    Medical practice

    Nephrology Gastroenterology

    Content type

    News
    Gastroenterology

    The blue poop challenge: a reliable method to evaluate gut transit?

    By Pr. Gianluca Ianiro Gastroenterology Department, Fondazione Policlinico Universitario Agostino Gemelli- ...

    Find out more

    New perspectives in autism: the role of microbiota in social communication

    Overview By Dr. Vincent Trebossen Child and Adolescent P...

    Find out more

    Gut microbiota #15

    By Pr. Markku Voutilainen Turku University Faculty of Medicine; Turku University Hospital, Department of Ga...

    Find out more

    Microbiome topics at gastro 2021

    Congress Review By Pr. Eamonn M M Quigley Lynda K and David M Underwood Center for Digestive Disorders, Di...

    Find out more

    Commensal clostridiales strains mediate effective anti-cancer immune response against solid tumours

    Commented articles - Adults' section By Pr. Harry Sokol ...

    Find out more

    Microbiota in covid-19 pandemic

    Overview By Pr. Conceição Calhau NOVA Medical School, New University of Lisbon, Portugal By Pr. Pedro Povo...

    Find out more

    Association between fungal dysbiosis and environment

    The fungal portion of the gut microbiota (or mycobiota) has been much less studied than the bacterial porti...

    Find out more

    From diarrhea to chronic diseases: the well-documented consequences of antibiotic-related gut microbiota dysbiosis

    Antibiotic treatment may sometimes take place without any...

    Find out more

    Continue reading

    News
    22.11.2021

    Irritable bowel syndrome: is fecal microbiota transplantation effective in the long term?

    Read the article
    Cancer du pancréas : un diagnostic précoce non invasif grâce au microbiote fécal ?
    16.06.2022

    Pancreatic cancer: non-invasive early diagnosis thanks to the fecal microbiota?

    Read the article
    Photo: Régime méditerranéen « vert » : quels liens entre santé cardiométabolique et microbiote intestinal ?
    10.06.2022

    Green Mediterranean diet: what links between cardiometabolic health and gut microbiota?

    Read the article
    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria
    02.06.2022

    Immune checkpoint inhibitor (ICI) efficacy: the right dose of bacteria

    Read the article
    18.05.2022

    Gut microbiota and vitamin D: a promising team in the fight against osteoporosis?

    Read the article
    Photo: Neonatal sepsis: the microbiota pays a heavy price for antibiotic use
    09.05.2022

    Neonatal sepsis: the microbiota pays a heavy price for antibiotic use

    Read the article
    26.04.2022

    Severe obesity: the vicious circle of biotin metabolism

    Read the article
    22.04.2022

    SCFAs: new intestinal markers of Parkinson’s disease?

    Read the article
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    NL13_cover
    Check out latest newsletter
    IBS, Microbiota & Covid-19
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español
    • Russian
    • Portuguese

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Photo: Postménopause : l'action bénéfique de l'estradiol sur le microbiote vaginal
    22.06.2022

    Postmenopause: the beneficial action of estradiol on the vaginal microbiota

    Read the article
    WMD_Foundation KOL USA 2018
    17.06.2022

    Dr. Yang (USA winner 2018): Gut microbiota & gut brain axis

    Read the article
    WMD_Foundation KOL USA 2017
    17.06.2022

    Dr. Singh (USA winner 2017): Microbiota & polyphenols

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive once a month the “Microbiota Digest” to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographic
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo